Schechter Investment Advisors’s Gilead Sciences GILD Stock Holding History

Schechter Investment Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$661K	Sell	5,903 -1,778	-23%	-$183K	0.05%	306
2024 Q4	$710K	Buy	7,681 +243	+3%	+$21.9K	0.05%	309
2024 Q3	$624K	Buy	7,438 +166	+2%	+$12.7K	0.05%	353
2024 Q2	$499K	Buy	7,272 +1,012	+16%	+$67.5K	0.04%	373
2024 Q1	$459K	Sell	6,260 -1,850	-23%	-$142K	0.03%	395
2023 Q4	$657K	Sell	8,110 -754	-9%	-$58.7K	0.06%	304
2023 Q3	$664K	Sell	8,864 -44	-0.5%	-$3.38K	0.06%	292
2023 Q2	$687K	Buy	8,908 +803	+10%	+$64K	0.06%	319
2023 Q1	$673K	Sell	8,105 -969	-11%	-$80.3K	0.06%	341
2022 Q4	$779K	Buy	9,074 +1,179	+15%	+$93.4K	0.07%	368
2022 Q3	$487K	Buy	7,895 +1,753	+29%	+$111K	0.05%	520
2022 Q2	$379K	Buy	+6,142	New	+$380K	0.04%	624
2022 Q1	–	Sell	-3,818	Closed	-$277K	–	946
2021 Q4	$277K	Buy	+3,818	New	+$263K	0.03%	698

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Schechter Investment Advisors's GILD Position: Q1 2025 in Review

Schechter Investment Advisors reduced its Gilead Sciences (GILD) stake by 23% in Q1 2025, selling an estimated $183K and leaving 5,903 shares worth $661K. The position accounts for 0.05% of the portfolio, ranked #306.

Schechter Investment Advisors first reported a position in GILD in Q4 2021 and has held it in 13 quarters since. The position peaked at $779K in Q4 2022. 2,013 funds tracked by Wall St. Rank hold GILD as of Q1 2025.

Schechter Investment Advisors held 5,903 shares of Gilead Sciences worth $661K as of Q1 2025.
Schechter Investment Advisors sold 1,778 Gilead Sciences shares in Q1 2025, an estimated $183K.
Gilead Sciences made up 0.05% of Schechter Investment Advisors's portfolio in Q1 2025, its #306 holding.
Schechter Investment Advisors first reported a position in Gilead Sciences in Q4 2021 and has held it in 13 quarters since.
Schechter Investment Advisors's Gilead Sciences position peaked at $779K in Q4 2022.
2,013 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2025.

Based on Schechter Investment Advisors's 13F filing for Q1 2025, filed 1 May 2025.